Microwave Ablation System Market

The microwave ablation system market is segmented on the basis of device type and application. The device type segment includes endoscopic ablation systems, interventional ablation systems, and diagnostic ablation systems. The application segment includes breast cancer, brain tumors, pancreatic cancer, and others. Microwave ablation occurs due to the direct heating of the tissue when the energy is deposited in the tissue-delivery antenna. As compared to this, RFA creates heat via resistive heating when electrical current passes through the ionic tissue medium, and hence would require an electrically conductive path.

The global microwave ablation system market was estimated to be US$ XX  billion in 2018 and is expected to grow at a CAGR of **% during the forecast period of 2019–2031. The market is divided into three segments: medical, industrial, and consumer products.

Ablation systems use heat (usually generated by radio frequency, RF, energy, or a laser) or extreme cold to cause small burns. These lesions create scar tissue that blocks electrical signals, causing arrhythmia. These procedures are guided by EP electro-mapping systems. Ablation is the surgical removal of tumors, cysts, and other growths using heat and electrical energy. The practice of microwave ablation has emerged as a novel technique for treating various types of tumors, including pancreatic cancer.

Some of the key players in the microwave ablation system market include AngioDynamics Inc., Medtronic Plc., Perseon, Medwaves Inc., NeuWave Medical Inc., Emblation Microwave Ltd., Miramar Labs Inc., Symple Surgical, Tactile Medical, and Urologix.